1200.36.0020 Boehringer Ingelheim Investigational Site

Memphis, Tennessee

0 studies enrolling now · 1 studies all time

What they study most

Glioma

Studies at this site

• BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma — Completed